Envista Holdings Corp SEC Filings

Envista Holdings Corp (NVST) CEO and director Paul A. Keel reported a Form 4 transaction. On 11/01/2025, 54,097 shares of common stock were withheld at $20.35 per share to satisfy tax obligations upon the vesting of stock‑settled restricted stock units (Transaction Code F). Following this withholding, Keel beneficially owns 347,555 shares directly.

Envista Holdings (NVST) reported Q3 results with sales of $669.9 million, up from $601.0 million a year ago. Operating profit rose to $57.5 million from $20.9 million as gross profit improved to $370.2 million. Despite pre‑tax income of $49.9 million, the company recorded a net loss of $30.3 million due to income tax expense of $80.2 million, driven primarily by a change in indefinite reinvestment assertions related to a foreign subsidiary.

Specialty Products & Technologies delivered $431.5 million in revenue and Equipment & Consumables $238.4 million. For the nine months, sales were $1,968.9 million, with net income of $14.1 million versus a prior‑year loss that included significant impairments. Cash and equivalents were $1,133.9 million, supported by $167.7 million of operating cash flow. Long‑term debt was $1,445.4 million, reflecting revolver usage and term loans; the company repaid $116.3 million as its 2025 convertible notes matured. Shares outstanding were 164,426,233 as of October 24, 2025.

Envista Holdings Corporation (NVST) furnished a press release announcing financial results for the quarter ended September 26, 2025. The release is provided as Exhibit 99.1.

The company also plans to reference a slide deck during its conference call on October 30, 2025 to discuss these results. The presentation is available on the Investors section of its website. The disclosures under Items 2.02 and 7.01 are being furnished and are not deemed filed.

Envista Holdings Corporation (NVST) furnished an Item 7.01 update announcing the release of its Sustainability Report, highlighting actions and progress across environmental, social, and governance topics. The report is available on the company’s website, and the related press release is furnished as Exhibit 99.1.

The information was furnished, not filed, under Regulation FD, and is incorporated by reference only if specifically referenced in future filings.

Envista Holdings Corporation disclosed that director Barbara B. Hulit resigned from the Board effective September 26, 2025. The resignation was submitted on September 15, 2025, and is to pursue another opportunity. The company stated the departure was not due to any disagreement with the Company on operations, policies, or practices.

Robert Befidi, President, Diagnostics of Envista Holdings Corp (NVST), reported a Form 4 filing showing a non-derivative disposition of 3,454 shares of common stock on 08/25/2025 at a price of $21.12 per share. The filing states these shares were withheld to satisfy tax withholding obligations related to vested restricted stock units. After the transaction, Mr. Befidi beneficially owned 45,504 shares. The Form 4 was signed by Heather Turner by power of attorney on 08/27/2025.

Envista Holdings Corp (NVST) insider sale disclosure: Chief Financial Officer Eric D. Hammes reported the disposition of 7,654 shares of Envista common stock on 08/25/2025 at a reported price of $21.12 per share. After the transaction, Hammes beneficially owned 96,788 shares. The filing explains these shares were withheld to satisfy tax-withholding obligations related to the vesting of stock-settled Restricted Stock Units, indicating the transaction was not an open-market sale but a net settlement of equity awards. The Form 4 was signed by a power of attorney on 08/27/2025.

Stefan Nilsson, an officer and director of Envista Holdings Corp (NVST) and listed as President, Nobel Biocare, reported a routine disposition of the issuer's common stock. On 08/25/2025 Code F activity shows 804 shares were disposed at $21.12 per share. The filing explains these shares were withheld to satisfy tax withholding obligations arising from the vesting of stock-settled Restricted Stock Units. After this transaction Nilsson beneficially owned 54,941 shares in a direct ownership form. The Form 4 was signed by Heather Turner by power of attorney on 08/27/2025.

Envista Holdings Corp (NVST) reporting person Veronica Acurio, identified as President, Orthodontics and an officer/director, had 5,422 shares of common stock withheld to satisfy tax-withholding on vested restricted stock units. The transaction is reported as a disposition at an effective price of $21.12 per share on 08/25/2025, leaving 50,323 shares beneficially owned following the withholding.

This Form 4 describes a routine tax-related withholding tied to equity compensation rather than an open-market sale; no options, derivatives or other transactions are reported.